Information for the AD summit

Preprints

#ASAPbio

During the panel discussion @ASAPbio_’s @jessicapolka, @biorxivpreprint’s @JohnRInglis, @YODAProject’s @jsross119 & @CellPressNews’s @biologyfan discussed #preprints & and their expansion to clinical medicine at #BMTS19 #asapbio

Reply on Twitter Retweet on Twitter Like on Twitter2 Twitter

Ulrike Boehm 🔬👩🏻‍💻@Ulrike_Boehm·

15 Feb

.@biorxivpreprint’s @JohnRInglis talked about the power of #preprints, @medrxivpreprint & new ways of evaluating outputs etc (@preLights @PREreview_ etc) at #BMTS19 - My conclusion: Join the movement!!! @CBMRT_org #asapbio #elifeambassadors

Reply on Twitter Retweet on Twitter Like on Twitter2 Twitter

Adriana Bankston @AdrianaBankston·

15 Feb

One important aspect from @jessicapolka of #preprint acceptance is to make them open, not just free, as the majority of #preprints are not open access. #BMTS19 #ASAPbio 13/n

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Adriana Bankston @AdrianaBankston·

15 Feb

More from @jessicapolka on concerns that preprints will not be considered a legitimate publications for #ECRs, and how to ensure that #ECRs are getting credit for their #peerreview efforts #BMTS19 #ASAPbio 12/n

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Adriana Bankston @AdrianaBankston·

15 Feb

. @jessicapolka reminds us that knowledge can build on prior knowledge, however publication in cell biology is taking longer and longer. #BMTS19 #ASAPbio 11/n

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Devang Mehta @drdevangm·

14 Feb

The other problem with this proposal is that it reinforces the current paradigm where "curated" papers acquire a patina of truth that's hard to refute subsequently. One of motivations of #asapbio is to abandon this harmful premise. See for a recent e.g.:

Reply on Twitter Retweet on Twitter Like on Twitter Twitter